Trial Management Associates (TMA) is an exclusive network of investigative
sites conducting phase II-
Trial Management Associates (TMA) is an exclusive network of investigative
sites conducting phase II-IV clinical research.
April 2023 Newsletter Volunteer Now Trial Management Associates Newsletter Spring into Research, We hope the sunshine and warmer weather have given you a chance to get out and enjoy springtime
Are you interested in participating in clinical research? We would love to share with you how to get involved!!! Come meet our team and learn more at the WWAY Family and Kids Expo. March 26th, 2023
12-4PM Independence Mall.
Interested in participating in clinical research?? We would love to talk with you! Our board certified physicians, Pharm-D and clinically trained staff are always here to answer any questions you may have. Check us out at www.trialmgt.com or call us at 910-833-1954 to learn more.
We are looking for participants ages 65+ to be part of our FLU vaccine trial. If you have not received your FLU shot and are interested in participating please contact us at 910.833.1954 or visit us at www.trialmgt.com.
The purpose of this clinical trial is to assess the safety of an investigational vaccine aimed at protecting adults against Influenza (Flu). Influenza is a potentially serious disease that can lead to hospitalization and sometimes even death.
Every Flu season is different and the Flu can affect people differently, but millions of people get the Flu every year. Complications of Flu can include bacterial pneumonia, ear infections, sinus infections, and worsening of chronic medical conditions such as CHF, asthma or diabetes. New vaccines must be tested to show that they will work. By participating you will get protected against Influenza and help us test a new novel FLU Vaccine.
The total length of participation in this clinical trial is approximately 6 months. It includes up to 4 visits to the clinical trial site and weekly communications via e-diary. To learn more call us at 910.833.1954 or visit us at www.trialmgt.com
Happy New Year, Check out our January Newsletter below for information on upcoming trials and events!
January 2023 Newsletter Volunteer Now Trial Management Associates Newsletter Happy New Year, We hope 2023 is off to a wonderful start. We want to share what is happening at TMA and how we can
Shape the future—join the Moderna Trio P101 Trial evaluating investigational mRNA vaccines targeting Flu, RSV, and COVID.
If you are between the ages of 50-75 Call 910-833-1954 or email us at [email protected] to learn more about participating.
Join the Moderna Trio P101 Trial—potentially help change the future of investigational mRNA Flu/RSV/COVID vaccines.
We are currently screening patients for the TRIO Trial aimed at protecting against the "tripledemic"! If you are interested in participating to protect against FLU, RSV, and COVID contact us at:
910-833-1954 or [email protected]
Experts tell ABC News with cases of flu and RSV rising earlier than usual and the threat of COVID still looming, the U.S. could see a 'tripledemic' this fall and winter.
We are actively screening and scheduling for our FLU Vaccine Trials! Contact us at 910-833-1954 if you are interested in participating!
A vaccine trial is taking place in Wilmington as researchers hope to better tackle flu season using mRNA technology.
We are actively enrolling patients for our FLU vaccine trials.
Contact us at 910-247-4580 to enroll
Flu season is approaching in the United States. Here's what you can expect this year — and when to get your flu vaccine to help you stay safe.
As we are in the peak of flu season, some doctors have reached a peak point of research, as they're working to roll out an improved influenza vaccine.Myrtle Bea
Seasonal Flu Research Study. Volunteers Needed. Compensation for time and travel!
Find out more about this clinical trial today!
We need healthy volunteers to take part in a clinical trial for an investigational mRNA Flu vaccine. Be a pioneer for research today!
Stand up to Seasonal Flu. Volunteers Needed. Flu Research Study
We need healthy volunteers to take part in a clinical trial for an investigational mRNA Flu Vaccine.
Compensation for time and travel.
An alarming spike in COVID-19 and flu cases in Australia could put the U.S. on track for what health experts call a “twindemic” – a dangerous viral one-two punch in the months ahead.
Interested in quitting smoking? Now you can!!! Let us help you!! We are actively enrolling patients today!! Contact TMA at 910-247-4580 or visit us at www.trialmgt.com
Investigational treatment may help adult cigarette smokers who want to quit. Click on link to learn more!
Contact Trial Management Associates to learn how you can become part of this cutting edge clinical trial enrolling now.
910.247.4580 or www.trialmgt.com
We are actively enrolling patients for this clinical trial. If you have tried to quit smoking and have been unsuccessful and would like to be part of this cutting edge research please contact us at 910-247-4580 or visit us at www.trialmgt.com
For the first time in 20 years, smoking numbers have increased significantly. Medical experts say, the pandemic is partly to blame for that.
From lemon tea with honey to cough drops and piles of tissues, we all have a plan of attack when we’re fighting the flu. But what if there might be a better way to try to prevent those miserable bedridden days? We’re currently recruiting healthy adults to take part in a clinical trial on investigational mRNA influenza (flu) vaccines. Learn more today by contacting Trial Management Associates at 910.247.4580 www.trialmgt.com
We’re looking for adults 18 and older who have received two primary doses and one investigational booster dose of the Moderna COVID-19 vaccine at least three months ago to take part in this booster study. This important research may help us better understand how to protect ourselves from new COVID-19 variants. To find out how you can get involved:
VISIT www.trialmgt.com for more information.
CALL 910-247-4580 or EMAIL [email protected]
Want to get involved in Research? Join our TMA community!
TMA is actively enrolling participants for our upcoming clinical trials!!! Compensation for time and travel!!
To see if you may qualify for one of our studies
contact us at 910-247-4580!!!
Frequent HEARTBURN??? A new clinical trial might be able to help. You could qualify if you have experienced heartburn for at least the last 6 months. Now Enrolling! Learn more at www.trialmgt.com or call us at 910-362-1011 x 160
A North Carolina-based clinical trial company is opening shop in Myrtle Beach. Trial Management Associates was chosen as one of only ten sites in the country to conduct Moderna's COVID-19 vaccine trial. The company's president,Phil Dattilo, said they chose Myrtle Beach to expand their research becau...
The company will create dozens of new jobs in the medical field in the Grand Strand, and it is looking for volunteers to participate in paid research studies.
We are proud to be part of the Phase 3 ORCA-3 clinical study! Are you a daily cigarette smoker and have failed at least one previous attempt to stop smoking with or without therapeutic support? If so, you may qualify for the ORCA-3 study.
Contact us at 910-247-4580 or Visit our website for more information: www.trialmgt.com
TMA's current RSV study was featured on WECT this evening! If you are 60 years or older and want to participate in the study call 910-338-1555 for more information. https://www.wect.com/2021/08/24/wilmington-clinical-trial-possible-rsv-vaccine-kicks-off-hospital-sees-abnormal-increase-cases/
Unfortunately COVID-19 isn’t the only respiratory virus going around.
**Please see our press release below for information about new studies coming to TMA. As always, call 910-338-1555 with questions or for more information!**
WILMINGTON, NC, (July 30, 2021)— Wilmington emerged as a key testing site for vaccines and other therapies on the national stage in 2020. Science continues to push forward with therapies for new and emerging viruses, and Wilmington will continue to play an important role. Significant advances are occurring in the fight against diseases and viruses—most pressingly respiratory syncytial virus (RSV), for which there is currently no approved vaccine. Trial Management Associates, LLC (TMA), an integrated site network based in Wilmington, is gearing up for an influx of new trials to bring these exciting new therapies to the market.
“The Wilmington community went above and beyond over the last year and is continuing to help advance new therapies through clinical trials,” says Phil Dattilo, President of TMA. “Now we have the opportunity to expand vaccines and therapies into unmet needs such as flu, RSV, mononucleosis, and shingles. RSV will be in the forefront in 2021 and 2022, and TMA will need volunteers over the age of 60.”
What is RSV?
Respiratory Syncytial Virus (RSV) is a common respiratory condition that presents with cold-like symptoms including runny nose, coughing, sneezing, and fever. It arises seasonally, and while it can be well-tolerated in most individuals, it can cause complications including hospitalization, pneumonia, and worsening of lung conditions such as COPD in the elderly and the very young. According to the Centers for Disease Control (CDC), more than 144,000 individuals are hospitalized due to RSV, and more than 14,000 die due to RSV complications each year. The CDC also reports that there have been recent spikes in RSV transmission and infection, including 173 hospitalizations nationwide in the months of April and May 2021, with the most significant increases in cases coming from southeastern states.
Due to the increase of available studies for the Wilmington community, TMA is seeking volunteers ages 60 and older for the RSV trials as well as volunteers ages 18 and older for additional clinical trial opportunities. All patients will be compensated for their time and travel. If anyone in Wilmington, NC, and the surrounding communities would like more information or sign up to participate in upcoming studies, please contact TMA at [email protected] or call the TMA office at 910-338-1555.
If you are interested in our RSV trial, other upcoming studies, or want to learn more about clinical research, give us a call at 910-338-1555! Our staff is so excited to offer these opportunities to the Wilmington community!
Wilmington-based Trial Management Associates is working to play a role in advancing more treatments through its clinical trials with a trial therapy for RSV, according to a news release. Trial Management Associates (TMA), a clinical research management company that has an integrated site network i...
Respiratory Syncytial Virus continues to spread across the South, impacting the very young and older adults. TIME magazine explains why... https://time.com/6082836/rsv-spike-summer-2021/
And what parents should know
TRIAL MANAGEMENT ASSOCIATES (TMA) ANNOUNCES
TWO NEW CORONAVIRUS VACCINE TRIALS
TO TAKE PLACE IN WILMINGTON, NC
TMA and Wrightsville Family Practice are currently seeking
volunteers from the Wilmington area for the trials
See our press release on our website: www.trialmgt.com.
Volunteer today! Call 910-247-4580.
Trial Management Associates (TMA) is an exclusive network of investigative sites, based at private physician practices, conducting phase II-IV clinical research studies.
The trials began over the summer and are expected to continue for up to two years
Trial Management Associates and Wrightsville Family Practice are currently seeking volunteers for a COVID-19 vaccine trial to begin in mid-July in the Wilmington area.
Wilmington will be one of many sites around the county to take part in a third-phase trial for the development of a potential coronavirus vaccine. Trial Management Associates LLC (TMA), along with Bart Williams and Will Jones, two physicians at Wrightsville Family Practice, have been selected to c...
We are actively seeking study volunteers for the Phase III coronavirus vaccine trial. Please email: [email protected] with your name, number, and email address.
Researchers are recruiting volunteers for the final phase before FDA approval
Moderna has chosen Wilmington as one of ten sites nationwide to conduct phase two of its clinical trial for a COVID-19 vaccine.
A Wilmington-based clinical research management company and a local family practice have been selected for the second phase of a coronavirus vaccine trial, which could help fight COVID-19, according to a news release. Cambridge, Massachusetts-based Moderna Inc. selected Trial Management Associates ...
Wrightsville Family Practice and the research team at TMA are currently conducting a clinical research study for development of a COVID-19 (Coronavirus) vaccine. Qualified participants would be healthy persons, 18 - 54 years of age who have not been tested for or exposed to COVID-19. Compensation up to $950.00 is available for time and travel. Please call 910-247-4580 to see if you are eligible.
1221 Floral Pkwy Suite 101
Be the first to know and let us send you an email when Trial Management Associates, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Business
Send a message to Trial Management Associates, LLC:
Other Wilmington clinics
Medical Center Drive
Military Cutoff Road
Don’t miss this chance to be a part of the community at one of the most anticipated senior events of the year!